Abstract
Hereditary hyperekplexia, or familial startle disease (STHE), is an autosomal dominant neurologic disorder characterized by marked muscle rigidity of central nervous system origin and an exaggerated startle response to unexpected acoustic or tactile stimuli. Linkage analyses in several large families provided evidence for locus homogeneity and showed the disease gene was linked to DNA markers on the long arm of chromosome 5. Here we describe the identification of point mutations in the gene encoding the α1 subunit of the glycine receptor (GLRA1) in STHE patients from four different families. All mutations occur in the same base pair of exon 6 and result in the substitution of an uncharged amino acid (leucine or glutamine) for Arg271 in the mature protein.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Kirstein, L. & Silfverskiold, B.P. A family with emotionally precipitated “drop seizures.” Acta Physchiatr. neurol. Scand. 33, 471–476 (1958).
Suhren, O., Bruyn, G.W. & Tuynman, J.A. Hyperekplexia: a hereditary startle syndrome. J. neurol. Sci. 3, 577–605 (1966).
Andermann, F., Keene, D.L., Andermann, E. & Quesney, L.F. Startle disease or hyperekplexia: further delineation of the syndrome. Brain 103, 985–997 (1980).
Ryan, S.G. et al. Startle disease or hyperexplexia: response to clonazepam and assignment of the gene (STHE) to chromosome 5q by linkage analysis. Ann. Neurol. 31, 663–668 (1992).
Nigro, M.A. & Lim, H.-C.N. Hyperekplexia and sudden neonatal death. Pediatr. Neurol. 8, 221–225 (1992).
Giacoia, G.P. & Ryan, S.G. Hyperekplexia as a cause of apnea and sudden infant death syndrome. Am. J. dis. Child (in the press).
Markand, O.N., Garg, B.P. & Weaver, D.D. Familial startle disease (hyperekplexia): electrophysical studies. Arch. Neurol. 41, 71–74 (1984).
Brown, P. et al. The hyperekplexias and their relationship to the normal startle reflex. Brain 114, 1903–1928 (1991).
Matsumoto, J., Fuhr, P., Nigro, M. & Hallett, M. Physiological abnormalities in hereditary hyperekplexia. Ann. Neurol. 32, 41–50 (1992).
Davis, M., Cederbaum, J.M., Aghajanian, G.K. & Gendelman, D.S. Effects of clonidine on habituation and sensitization of acoustic startle in normal, decerebrate and locus coeruleus lesioned rats. Psychopharmacology 47, 217–233 (1976).
Warrington, J.A. et al. A radiation hybrid map of 18 growth factor, growth factor receptor, hormone receptor or neurotransmitter receptor genes on the distal region of the long arm of chromosome 5. Genomics 13, 803–808 (1992).
Puckett, C. et al. Molecular cloning and chromosomal localization of one of the human glutamate receptor genes. Proc. natn. Acad. Sci. U.S.A. 88, 7557–7561 (1991).
Buckle, V.J. et al. Chromosomal localization of GABAA receptor subunit genes: relationship to human genetic disease. Neuron 3, 647–654 (1989).
Wasmuth, J.J., Bishop, D.T. & Westbrook, C.A. Report of the committee on the genetic constitution of chromosome 5. In Human Gene Mapping 11, Cytogenet. Cell Genet. 58, 261–294 (1991).
Ryan, S.G. et al. Genetic and radiation hybrid mapping of the hyperekplexia region on chromosome 5q. Am. J. hum. Genet. 51, 1334–1343 (1992).
Warrington, J.A., Bengtsson, U., Bailey, S.K., Lovett, M. & Wasmuth, J.J. A comparison of three methods to produce a high resolution physical map of 11 genes on the distal region of the long arm of human chromosome 5: radiation hybrid mapping, pulsed-field gel electrophoresis and fluorescent in situ hybridization. Am. J. hum. Genet. 51(suppl), A248 (1992).
Grenningloh, G. et al. The strychnine-binding subunit of the glycine receptor shows homology with nictonic acetylcholine receptors. Nature 238, 215–220 (1987).
Heller, A.H. & Hallet, M. Electrophysiological studies with the spastic mutant mouse. Brain Res. 234, 299–308 (1982).
Grenningloh, G. et al. Alpha subunit variants of the human glycine receptor: primary structures, functional expression and chromosomal localization of the corresponding genes. EMBO J. 9, 771–776 (1990).
Malosio, M.-L. et al. Alternative splicing generates two variants of the α1 subunit of the inhibitory glycine receptor. J. biol. Chem. 264, 2048–2053 (1991).
Tebecis, A.K. & DiMaria, A. Strychnine-sensitive inhibition in the medullary reticular formation: evidence for glycine as an inhibitory transmitter. Brain Res. 40, 373–383 (1972).
Davis, M., Gendelman, M., Tischler, D. & Gendelman, P.M. A primary acoustic startle circuit: lesion and stimulation studies. J. Neurosci. 2, 791–805 (1982).
Krnjevic, K. Transmitters in motor systems. In Handbook of Physiology (ed. Geiger, S.R.) 107–154 (American Physiology Society, Bethesda, Maryland, 1981).
Langosch, D., Becker, C.-M. & Betz, H. The inhibitory glycine receptor: a ligand-gated chloride channel of the central nervous system. Eur. J. Biochem. 194, 1–8 (1990).
Becker, C.-M., Hoch, W. & Betz, H. Glycine receptor heterogeneity in rat spinal cord during postnatal development. EMBO J. 7, 3717–3726 (1988).
Schmieden, V., Grenningloh, G., Schofield, P.R. & Betz, H. Functional expression in Xenopus oocytes of the strychnine binding 48 kd subunit of the glycine receptor. EMBO J. 8, 695–700 (1989).
Becker, C.-M., Schmieden, B., Paola, T., Strasser, U. & Betz, H. Isoform-selective deficit of glycine receptors in the mouse mutant spastic. Neuron 8, 283–289 (1992).
Eicher, E.M. & Lane, P. Assignment of LG XVI to chromosome 3 in the mouse. J. Hered. 71, 315–318 (1980).
Lane, P.W., Ganser, A.L., Kerner, A.L., White, W.F. Spasmodic, a mutation on chromosome 11 in the mouse. J. Hered. 78, 353–356 (1987).
Buckwalter, M.S., Testa, C.M., Noebels, J.L. & Camper, S.A. Genetic mapping and evaluation of candidate genes for spasmodic, a neurological mouse mutation with abnormal startle response. Genomics 17, 279–286 (1993).
Dana, S. & Wasmuth, J.J. Linkage of the leuS, emtB, and chr genes on chromosome 5 in humans and expression of human genes encoding protein synthesis components in human-Chinese hamster hybrids. Somatic cell Genet. 8, 245 (1982).
Overhauser, J., McMahon, J. & Wasmuth, J.J. Identification of 28 DNA fragments that detect RFLPs in 13 distinct physical regions of the short arm of chromosome 5. Nuc. Acids Res. 15, 4617 (1987).
Cox, D.R., Burmeister, M., Price, E.R., Kim, S. & Myers, R.M. Radiation hybrid mapping: a somatic cell genetic method for constructing high resolution maps of mammalian chromosomes. Science 250, 245–250 (1990).
Sheffield, V.C., Cox, D.R., Lerman, L.S. & Myers, R.M. Attachment of a 40-base-pair G+C sequence (GC-clamp) to genomic DNA fragments by the polymerase chain reaction results in improved detection of single-base changes. Proc. natn. Acad. Sci. U.S.A. 86, 232–236 (1989).
Myers, R.M., Maniatis, T. & Lerman, L.S. Detection and localization of single base changes by denaturing gradient gel electrophoresis. Meth. Enzymol. 155, 501–527 (1987).
Lerman, L.S. & Silverstein, K. Computation simulation of DNA melting and its application to denaturing gradient gel electrophoresis. Meth. Enzymol. 155, 482–501 (1987).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Shiang, R., Ryan, S., Zhu, YZ. et al. Mutations in the α1 subunit of the inhibitory glycine receptor cause the dominant neurologic disorder, hyperekplexia. Nat Genet 5, 351–358 (1993). https://doi.org/10.1038/ng1293-351
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ng1293-351
This article is cited by
-
Comprehensive behavioral analyses of mice with a glycine receptor alpha 4 deficiency
Molecular Brain (2023)
-
Structural basis for cannabinoid-induced potentiation of alpha1-glycine receptors in lipid nanodiscs
Nature Communications (2022)
-
Architecture and assembly mechanism of native glycine receptors
Nature (2021)
-
Advances in hyperekplexia and other startle syndromes
Neurological Sciences (2021)
-
Identification of the hypertension drug niflumic acid as a glycine receptor inhibitor
Scientific Reports (2020)